United States

Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

29 Jul 2016
Change (% chg)

$-0.03 (-2.04%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for AEGR.O


Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of therapies for patients with debilitating rare diseases. It operates through pharmaceuticals segment. Its products include lomitapide and metreleptin. Lomitapide is a small molecule microsomal triglyceride transfer... (more)


Beta: 0.60
Market Cap(Mil.): $43.37
Shares Outstanding(Mil.): 29.50
Dividend: --
Yield (%): --


  AEGR.O Industry Sector
P/E (TTM): -- 39.19 39.69
EPS (TTM): -4.21 -- --
ROI: -35.69 15.23 14.44
ROE: -119.21 16.16 15.49

BRIEF-Aegerion Pharmaceuticals unveils cost reduction plans

* Aegerion Pharmaceuticals says intends to withdraw lomitapide from european union (eu) and certain other global market Source text for Eikon: Further company coverage:

Jul 20 2016

BRIEF-Aegerion pharmaceuticals, Qlt Inc agree to strategic merger

* Aegerion Pharmaceuticals and QLT Inc. agree to strategic merger

Jun 15 2016

BRIEF-Aegerion Pharmaceuticals files for $100 mln mixed shelf offering

* Aegerion Pharmaceuticals Inc files for $100 mln mixed shelf offering - SEC FILING Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

May 19 2016

BRIEF-Aegerion reaches preliminary agreements with DOJ and SEC on ongoing probe

* Aegerion Pharmaceuticals announces preliminary agreements in principle with DOJ and SEC related to ongoing investigations

May 12 2016

BRIEF-Aegerion pharmaceuticals enters into agreement with Sarissa Capital

* Pursuant to amendment standstill period has been deemed terminated as of march 21, 2016

Mar 22 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Stock Traders Daily
Provider : New Constructs, LLC
Provider : ValuEngine, Inc.
Provider : Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.